Private Equity
1 min read · 29 October 2009
1 min read · 28 October 2009
1 min read · 28 October 2009
1 min read · 28 October 2009
1 min read · 28 October 2009
Celtic Therapeutics, a private equity firm formed to acquire and invest in a diversified portfolio of 10 to 15 novel therapeutic product candidates, has received a $100 million investment commitment from PPD Inc. (Nasdaq: PPDI).
3 min read · 28 October 2009
Powercell Sweden AB, a maker of fuel cells, fuel reformers and auxillary power units, has raised SEK 60 million (US$8.53m) from Fouriertransform, an auto industry-focused VC firm sponsored by the Swedish government. This represents Fouriertransform's first investment.
4 min read · 28 October 2009
Deccan Healthcare, an India-based developer of nutraceutical products for boosting immunity and addressing chronic ailments, has raised 15 crore (US$3.2m) in VC funding from Nexus Venture Partners.
3 min read · 28 October 2009
Quinnova Pharmaceuticals Inc., a Newtown, Pa.-based dermatological drug company, has raised $17.4 million in Series B funding. Safeguard Scientifics led the round, and was joined by return backers Thomas, McNerney & Partners, H.I.G. Ventures and a syndicate led by Omnivest (Bermuda) Ltd. The company previously raised a $13.6 million Series A round in 2006.
5 min read · 28 October 2009
StatusNet, a Montreal-based developer of an open-source micro-blogging platform, has raised C$875,000 in seed funding. Backers include Montreal Start Up, iNovia Capital and Oleg Tscheltzoff (Fotolia.com).
3 min read · 28 October 2009